Balance Sheet
Accounts PayablesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current Deffered RevenueNotes PayablesOperating LeasesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

vTv Therapeutics (VTVT) Minority Interest (2016 - 2025)

Historic Minority Interest for vTv Therapeutics (VTVT) over the last 12 years, with Q2 2025 value amounting to -$357000.0.

  • vTv Therapeutics' Minority Interest fell 10901.06% to -$357000.0 in Q2 2025 from the same period last year, while for Jun 2025 it was -$357000.0, marking a year-over-year decrease of 10901.06%. This contributed to the annual value of $2.1 million for FY2024, which is 6571.52% down from last year.
  • Latest data reveals that vTv Therapeutics reported Minority Interest of -$357000.0 as of Q2 2025, which was down 10901.06% from $977000.0 recorded in Q1 2025.
  • vTv Therapeutics' Minority Interest's 5-year high stood at $62.6 million during Q1 2021, with a 5-year trough of -$357000.0 in Q2 2025.
  • In the last 5 years, vTv Therapeutics' Minority Interest had a median value of $15.1 million in 2022 and averaged $18.5 million.
  • Its Minority Interest has fluctuated over the past 5 years, first skyrocketed by 3642.37% in 2023, then tumbled by 10901.06% in 2025.
  • vTv Therapeutics' Minority Interest (Quarter) stood at $25.0 million in 2021, then crashed by 33.58% to $16.6 million in 2022, then crashed by 63.02% to $6.1 million in 2023, then plummeted by 65.72% to $2.1 million in 2024, then plummeted by 116.98% to -$357000.0 in 2025.
  • Its Minority Interest was -$357000.0 in Q2 2025, compared to $977000.0 in Q1 2025 and $2.1 million in Q4 2024.